Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone Acetate
Wataru Fukuokaya(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Taro Igarashi(Jikei University School of Medicine), Mariko Honda(Jikei University School of Medicine), Shunsuke Tsuzuki(Jikei University School of Medicine), Kenta Miki(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 15
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112
Extracellular vesicles in the development of organ‐specific metastasis
|Journal of Extracellular Vesicles|2021|101